SCHEMBL707316

SCHEMBL707316

CC[SiH2]Oc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CA4 P22748 1/20 0.42
LTA4H P09960 5/20 0.41
TSHR P16473 1/20 0.39
KCNA3 P22001 1/20 0.39
CHRNB2 P17787 2/20 0.38
CHRNB4 P30926 2/20 0.38
CHRNA3 P32297 2/20 0.38
CHRNA7 P36544 2/20 0.38
CHRNA4 P43681 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.36
TP53 P04637 1/20 0.36
LMNA P02545 1/20 0.35
HTR1D P28221 1/20 0.35
HTR1B P28222 1/20 0.35
TAAR1 Q96RJ0 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL705351 0.81 LTA4H (0.41) CA4LTA4HTSHRKCNA3CHRNB2
SCHEMBL705034 0.78 LTA4H (0.47) CA4LTA4HKCNA3LMNA
SCHEMBL28728730 0.76 LTA4H (0.47) LTA4HTSHRKCNA3LMNA
SCHEMBL27809250 0.75 TAAR1 (0.44) CA4LTA4HTSHRKCNA3TAAR1
Butane SCHEMBL2501351 0.75 LTA4H (0.43) CA4LTA4HTSHRKCNA3CHRNB2
SCHEMBL28728879 0.72 KCNA3 (0.52) LTA4HKCNA3CHRNB2CHRNB4CHRNA3
SCHEMBL31187717 0.72 SLC6A4 (0.36) CA4LTA4HTSHRKCNA3CHRNB2
SCHEMBL2115179 0.71 LTA4H (0.43) CA4LTA4HTSHRKCNA3CHRNB2
SCHEMBL706293 0.70
SCHEMBL10570045 0.70 LTA4H (0.42) CA4LTA4HTSHRKCNA3CHRNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12575570-B2 Aqueous composition of Epyrifenacil, Mesotrione and Pyroxasulfone VALENT U.S.A., LLC (US) 2026-03-17 US disclosed
US-12369587-B2 Aqueous composition of epyrifenacil, flumioxazin and pyroxasulfone VALENT U.S.A., LLC (US) 2025-07-29 US disclosed
US-12098150-B2 Crystal of heterocyclic amide compound and method for producing same NISSAN CHEMICAL CORPORATION (JP) 2024-09-24 US disclosed
EP-3939977-B1 CRYSTAL OF HETEROCYCLIC AMIDE COMPOUND AND METHOD FOR PRODUCING SAME NISSAN CHEMICAL CORP (JP) 2024-05-08 EP disclosed
EP-3507104-B1 PRODUCTION OF CIS-1,4-POLYDIENES WITH MULTIPLE SILANE FUNCTIONAL GROUPS PREPARED BYIN-SITU BRIDGESTONE CORP (JP) 2024-03-27 EP disclosed
WO-2022138821-A1 DISPERSIBLE CONCENTRATED AGROCHEMICAL FORMULATION 日産化学株式会社 2022-06-30 WO disclosed
WO-2022131217-A1 METHOD FOR MANUFACTURING COATED GRANULAR FERTILIZER, AND COATED GRANULAR FERTILIZER 住友化学株式会社 2022-06-23 WO disclosed
WO-2022118817-A1 AGROCHEMICAL COMPOSITION 住友化学株式会社 2022-06-09 WO disclosed
WO-2022118811-A1 AGROCHEMICAL COMPOSITION 住友化学株式会社 2022-06-09 WO disclosed
WO-2022119797-A2 AN AQUEOUS COMPOSITION OF EPYRIFENACIL, FLUMIOXAZIN AND PYROXASULFONE VALENT U.S.A. LLC (US) 2022-06-09 WO disclosed
CN-109715680-B Process for preparing high cis-1, 4-polydienes with lanthanide-based catalyst compositions 株式会社普利司通 2021-10-19 CN disclosed
WO-2021111789-A1 LIQUID AGROCHEMICAL COMPOSITION 住友化学株式会社 2021-06-10 WO disclosed
WO-2021039756-A1 CARNIVOROUS WASP ATTRACTANT アース製薬株式会社 2021-03-04 WO disclosed
WO-2021039757-A1 METHOD FOR PROMOTING DELIVERY OF POISON BAIT TO BEEHIVE アース製薬株式会社 2021-03-04 WO disclosed
EP-2864381-A1 PROCESS FOR PRODUCING A COMPOSITE MATERIAL BASF SE (DE) 2015-04-29 EP disclosed
WO-2014001273-A1 PROCESS FOR PRODUCING A COMPOSITE MATERIAL BASF SE (DE) 2014-01-03 WO disclosed
US-8124239-B2 Silica film forming material, silica film and method of manufacturing the same, multilayer wiring structure and method of manufacturing the same, and semiconductor device and method of manufacturing the same FUJITSU LIMITED (JP) 2012-02-28 US disclosed
US-20100155121-A1 SILICA FILM FORMING MATERIAL, SILICA FILM AND METHOD OF MANUFACTURING THE SAME, MULTILAYER WIRING STRUCTURE AND METHOD OF MANUFACTURING THE SAME, AND SEMICONDUCTOR DEVICE AND METHOD OF MANUFACTURING THE SAME FUJITSU LIMITED (JP) 2010-06-24 US disclosed
US-7659357-B2 Precursor organosilicon polymer of 1,2-Bis(dimethylethoxysilyl)ethane, 1,4-bis(dimethylethoxysilyl)benzene, tetraethoxysilane, methyltriethoxysilane, phenyltriethoxysilane; dielectric (DE) films having etching/chemical/moisture resistance; adhesion; low DE constant; minimal wiring delay; high speed FUJITSU LIMITED (JP) 2010-02-09 US disclosed
US-20070026689-A1 Silica film forming material, silica film and method of manufacturing the same, multilayer wiring structure and method of manufacturing the same, and semiconductor device and method of manufacturing the same FUJITSU LIMITED (JP) 2007-02-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12575570-B2 Aqueous composition of Epyrifenacil, Mesotrione and Pyroxasulfone ADRB3, CHRM3, GRM3 CA4 2678/4885LTA4H 891/4885TSHR 1527/4885
US-12369587-B2 Aqueous composition of epyrifenacil, flumioxazin and pyroxasulfone ADRB3, CHRM5, CHRM3 CA4 1466/4885LTA4H 285/4885TSHR 900/4885
US-12098150-B2 Crystal of heterocyclic amide compound and method for producing same DDT, HDHD5, AADAC CA4 602/4885LTA4H 1879/4885TSHR 1222/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.